COVID-19 vaccine
WHO is committed to whom?
April 26, 2023
FEATURES
The World Health Organization is supposed to be the lead global institution for health. But it is too easily influenced by powerful HICs and big private institutions in the programs they implement. The COVID-19 vaccine profits they raked in are just the most recent example of this.
Global COVID-19 Vaccine Inequality
May 27, 2022
IBON on the inefficiency of WHO’s COVAX mechanism
May 26, 2022
WHO should call the shots, but it hasn’t
May 18, 2022
FEATURES
The 75th World Health Assembly will be the third one under one of the world’s worst pandemics. What exactly will be the agenda when WHO action is stalling?
The TRIPS waiver on Covid-19 pharmaceuticals and the Big Pharma
June 2, 2021
There is a raging debate about whether or not the WTO should temporarily waive some intellectual property rights of Covid-19 pharmaceuticals. Developed countries oppose the proposal, but recently the US has announced its limited support, while the EU continues to wrangle over its necessity. For proponents, the waiver would speed up and scale up vaccine production and contribute to a faster vaccination process in poorer countries.
Vaccination too slow to stop COVID-19 spread
May 13, 2021
Mass vaccination PH: Throwing away our shots (Part Two)
April 15, 2021
The Philippines is not expected to be ahead of the vaccine race being a poor, non-industrial and import-dependent country. But despite our underdevelopment, we still deserve better and more efficient government handling of our predicament.
Mass vaccination PH: Throwing away our shots (Part One)
April 15, 2021
A number of Asian countries are seeing an increase in COVID with surges particularly large in South Asia and, in Southeast Asia, the Philippines. The Duterte administration has been telling us since last year that the arrival of vaccines is its ultimate solution but, dismally, these are coming in trickles.
Late rollout, slow vaccination
April 7, 2021
The number of COVID cases in the country has surpassed 800,000 and is projected to reach 1 million by end-April. Yet vaccine rollout remains slow and chaotic.
